Market Cap now £14.1m.
Cash at end June was £2.3m. £3.6m gross proceeds raised in November.
Recent Pulsiv fundraise put our stake their worth £10.9m.
So currently valued at less than Pulsiv stake and cash. In other words everything else in for free.
Seriously cheap - but then again I’ve thought that before and it got cheaper. |
Crazy isn't it.
I've bought enough but not selling so just paper loses at the moment. I'm sure alot of other investors feel the same until there is news out.
A sell is clearly trying to get out and offloading... |
Somewhat rambling but quite useful.. |
Well I know didn’t benefit from further dilution but hey who cares about PI investors.
HNY all those PI who paid 28p might as well buy at 26p |
Just looked through who benefited from the recent handout, and I was reassured that a large number of shares went to non board members and that it wasn’t a simple grab as many as you can from the senior board. I have faith in this ceo, he’s acted pretty responsibly compared to many of his piers.
My view is the market views Frontier the same as nearly every other ‘jam tomorrow’ AIM company. The only difference is this company is the real deal in my opinion - which is probably what every other shareholder thinks of every other jam tomorrow company! |
Pulsiv remains the principal reason for me to hold here. Fipp mc of £15m with Pulsiv in the books at £10.9m. If their products sell as well as they hope there really is plenty of potential upside.
Again Fipp inability to keep shareholders informed on their website is really poor. I was trying to see who the rebel shareholder may have been based on major shareholders list - but it hasn’t been updated since last May.
More positively, amongst a list of achievements this year, Deakin Bio mentioned this today.
“Secured our first significant commercial order, to be completed in Q1 2025!” |
This does actually look like a very significant achievement;
hxxps://www.pulsiv.com/news-press/pulsiv-achieves-a-worlds-first-240w-usb-c-design |
It’s really turning sour this latest handout on top of a disastrous year for shareholders is a disgrace |
The BoD are starting to upset larger shareholders. At yesterday’s AGM, over 18% voted against the resolution to approve directors remuneration. You very rarely see that sort of level of dissatisfaction. |
Yup nnice work if you can get it. I did not see any mention of what the specifics were in the AGM. |
So much expected and so little delivered this year on many fronts.I had an online conversation on two occasions in the first few months of the year with Pulsiv.
In is words this year is going to be extremely exciting with some major news expected.
It’s been a year of so little value enhancing news if this continues next year we will be in exactly the same position having gone through a further dilution and an even lower valuation.
Delving deep in to the accounts with directors options and share transactions the ceo actually sold two lots of shares at a reasonable profit earlier in the year and was a added further options along with other board members also directors salary increased .
Obviously none of this related to share performance no shock their |
Christmas greetings from Pulsiv
“ As 2024 comes to an end, we'd like to extend our very best wishes to you and your families over the Christmas & New Year period.
We have our sights set firmly on 2025 in what is going to be a hugely exciting and successful year for Pulsiv. Watch this space! ”
Let’s hope they deliver on the expectations. |
Another 125k dumped by the seller. |
Now able to buy below the 28p placing 27.90 |
Fieldwork Robotics is pleased to announce an investment from August One through their Atlantico II Fund. The fund’s aim is to ‘Invest in Good. For Good’, and it seeks to invest in technology-driven solutions that can create lasting value for communities and the planet.
Ross Hunter will also join the board of Fieldwork as Investor Director, bringing August One’s expertise and guidance as we continue to scale our operations and impact globally.
This funding will allow us to further expand our R&D capabilities in Portugal and grow our team on the ground in Oeiras. We have been working in Portugal for several years now and we are looking forward to further developing our presence in the region.
Fieldwork is on a mission to provide raspberry growers around the globe with innovative harvesting solutions and this funding milestone is a great step forward in our scale up progress. |
Ah you also thinking of George Bernard Shaw's play but also very true in modern business |
Yes I had extremely high hopes for this investment but has you have pointed out above lots of disappointment in what was expected and what been delivered.
The Pulsiv lack of any significant sales news with all the worldwide distribution manufacturing partners in the electronics sector is totally baffling bizarre.
I may of commented before but these major companies that have partnered may have done so to delay stall any take up of the technology it’s sounds crazy but I’ve seen it with a company in the states called global food technology originally |
Until we get some firm RNSable news, and without an institution buying in big, it's difficult to see us making any progress.
The Alusid IPO this year ain’t happening.
CamGraphics expected £21m cash raise this quarter is now in its last 3 weeks.
Neil Crabb flagged up in that interview that shareholders were looking for news on Pulsiv customers soon. I remain hopeful they will pull a rather large rabbit from the hat before too long. |
Very subdued announcements given the opportunities on offer. Slightly frustrating the board are so cautious. However look what happened after the cautious valuations of exscentia… |
Ta re the above posts - I've picked up some more FIPP in the placing too.
At this share price, and given FIPP's high level of ownership in many of the investees, it will only take some good news from Pulsiv or one or two other companies being successful for the m/cap to be covered and more, let alone if a few succeed.
The latter seems much the more likely at present given the number of companies which have moved into the commercialisation and stage 4 phases of development. |
Neil Crabbs ProActive interview. |
Tipped in I/C by ST.
Of course, it is not ideal for Frontier IP to raise new equity at a 65 per cent discount to NAV, but equally it provides the headroom management need to deliver on portfolio realisations and working capital so that the business is not cash-constrained.
After the fundraising, the shares are rated at a 58 per cent discount to proforma NAV of 69.8p. For the share price discount to narrow significantly, shareholders will need to see realisations at close to carrying valuations. That seems highly likely. So, although the share price has been weak since the interim results (‘Exploit this investment company's 55% discount, 14 March 2024), I see recovery potential now that the company’s funding position is no longer an issue. Buy. |
 If you look at things negatively one could argue frontier has only had one successful exit so far… however they’ve got a few more potential blockbusters in the tank. We’re not investing in a social enterprise to nurture U.K. startups and only cover our costs, which is what frontier upto now has been. Frontier is in a difficult business and I’m guessing they get their ‘free equity stakes’ are from the man hours they invest in the businesses, so I wouldn’t question their wage bill too much, seems quite reasonable compared to other aim companies. It does seem to be an interesting time for Frontier with much of their portfolio reaching maturity.
Personally I’d argue from a national perspective these companies frontier invest in are the future lifeblood of our economy as a country, they shouldn’t really be relying on a tiny AIM company for their investment. Sure the government gives a steady stream of government grants to the portfolio and has increased the tax free incentives such as seis schemes. But they really do need to pull their finger out and get more capital flowing into early stage companies- good to see both political parties are focused on this with pension reforms to get life blood where it’s needed most to rejuvenate the economy. Let’s hope frontier start to see the effect of these future changes in the near term. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
